Inspire Medical Systems, Inc. (INSP) on Monday reported first-quarter results with revenue rising slightly from last year, though the company swung to a net loss amid higher expenses.
The company posted a net loss of $11.3 million, or $0.39 per share, compared with net income of $3.0 million, or $0.10 per share, in the year-ago period.
Revenue increased to $204.6 million from $201.3 million in the same period last year, reflecting continued demand for its sleep apnea treatment solutions.
For fiscal 2026, Inspire Medical expects revenue in the range of $825 million to $875 million, representing a 4 percent to 10 percent decline compared to 2025. The company also projects an adjusted operating margin of 2 percent to 4 percent and EPS between $0.07 and $0.62, with adjusted EPS expected in the range of $0.75 to $1.25.
INSP is currently trading after hours at $47.08, down $7.76 or 14.15 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.